96% Campaign Asks Obama To 'Pay Attention To Science' And Scale Up Global Access To ARVs
In this RH Reality Check opinion piece, Matthew Kavanagh, director of U.S. advocacy at Health GAP (Global Access Project), and Dazon Dixon Diallo, founder and president of SisterLove, Incorporated, write, “With proof that treatment is prevention, and with this basket of broader prevention options, scientists and economists have finally been able to show what few could before: models of how we end the AIDS crisis.”
“A revolutionized response to the global AIDS crisis has just been made possible with the August publication of a U.S.-funded study showing that antiretroviral AIDS medicines (ARVs) can cut the risk of HIV transmission from an infected to a non-infected partner by 96 percent,” the authors write, adding, “[T]his why we have launched the 96% Campaign to ask the President to pay attention to the science and pay attention to what people living with HIV need. Treatment is only one piece of the puzzle, but it is among the bedrock pieces” (10/7).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.